vs
INDEPENDENT BANK CORP（IBCP）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是INDEPENDENT BANK CORP的1.2倍（$69.8M vs $58.9M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 28.6%，领先355.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 2.1%）
独立银行公司（密歇根州）是一家总部位于密歇根州大急流城的银行机构，目前共开设62家营业网点，所有网点均布局于密歇根州境内，主要为当地市场提供各类银行金融服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
IBCP vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$58.9M
净利率更高
RIGL
高出355.4%
28.6%
两年增速更快
RIGL
近两年复合增速
2.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.9M | $69.8M |
| 净利润 | $16.9M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 28.6% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | 8.2% | 1769.2% |
| 每股收益（稀释后） | $0.81 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IBCPRIGL
| Q1 26 | $58.9M | — | ||
| Q4 25 | $58.3M | $69.8M | ||
| Q3 25 | $57.3M | $69.5M | ||
| Q2 25 | $55.9M | $101.7M | ||
| Q1 25 | $54.1M | $53.3M | ||
| Q4 24 | $62.0M | $57.6M | ||
| Q3 24 | $51.4M | $55.3M | ||
| Q2 24 | $56.5M | $36.8M |
净利润IBCPRIGL
| Q1 26 | $16.9M | — | ||
| Q4 25 | $18.6M | $268.1M | ||
| Q3 25 | $17.5M | $27.9M | ||
| Q2 25 | $16.9M | $59.6M | ||
| Q1 25 | $15.6M | $11.4M | ||
| Q4 24 | $18.5M | $14.3M | ||
| Q3 24 | $13.8M | $12.4M | ||
| Q2 24 | $18.5M | $-1.0M |
毛利率IBCPRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率IBCPRIGL
| Q1 26 | — | — | ||
| Q4 25 | 34.8% | 33.2% | ||
| Q3 25 | 37.0% | 40.9% | ||
| Q2 25 | 37.0% | 60.1% | ||
| Q1 25 | 35.3% | 23.9% | ||
| Q4 24 | 36.7% | 28.9% | ||
| Q3 24 | 33.7% | 25.4% | ||
| Q2 24 | 41.0% | 1.2% |
净利率IBCPRIGL
| Q1 26 | 28.6% | — | ||
| Q4 25 | 31.8% | 384.0% | ||
| Q3 25 | 30.5% | 40.2% | ||
| Q2 25 | 30.2% | 58.6% | ||
| Q1 25 | 28.8% | 21.5% | ||
| Q4 24 | 29.8% | 24.9% | ||
| Q3 24 | 26.9% | 22.5% | ||
| Q2 24 | 32.8% | -2.8% |
每股收益（稀释后）IBCPRIGL
| Q1 26 | $0.81 | — | ||
| Q4 25 | $0.88 | $14.11 | ||
| Q3 25 | $0.84 | $1.46 | ||
| Q2 25 | $0.81 | $3.28 | ||
| Q1 25 | $0.74 | $0.63 | ||
| Q4 24 | $0.87 | $0.82 | ||
| Q3 24 | $0.65 | $0.70 | ||
| Q2 24 | $0.88 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $174.9M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $510.6M | $391.5M |
| 总资产 | $5.6B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资IBCPRIGL
| Q1 26 | $174.9M | — | ||
| Q4 25 | $138.4M | $155.0M | ||
| Q3 25 | $208.7M | $137.1M | ||
| Q2 25 | $146.2M | $108.4M | ||
| Q1 25 | $128.1M | $77.1M | ||
| Q4 24 | $119.9M | $77.3M | ||
| Q3 24 | $121.6M | $61.1M | ||
| Q2 24 | $214.3M | $49.1M |
总债务IBCPRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益IBCPRIGL
| Q1 26 | $510.6M | — | ||
| Q4 25 | $503.0M | $391.5M | ||
| Q3 25 | $490.7M | $117.6M | ||
| Q2 25 | $469.3M | $81.9M | ||
| Q1 25 | $467.3M | $18.6M | ||
| Q4 24 | $454.7M | $3.3M | ||
| Q3 24 | $452.4M | $-14.6M | ||
| Q2 24 | $430.5M | $-29.9M |
总资产IBCPRIGL
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.5B | $513.6M | ||
| Q3 25 | $5.5B | $242.5M | ||
| Q2 25 | $5.4B | $206.7M | ||
| Q1 25 | $5.3B | $176.0M | ||
| Q4 24 | $5.3B | $164.0M | ||
| Q3 24 | $5.3B | $139.4M | ||
| Q2 24 | $5.3B | $128.4M |
负债/权益比IBCPRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IBCPRIGL
| Q1 26 | — | — | ||
| Q4 25 | $76.7M | $22.0M | ||
| Q3 25 | $18.2M | $24.0M | ||
| Q2 25 | $19.0M | $30.5M | ||
| Q1 25 | $31.7M | $-893.0K | ||
| Q4 24 | $63.2M | $14.5M | ||
| Q3 24 | $17.2M | $21.7M | ||
| Q2 24 | $8.7M | $302.0K |
自由现金流IBCPRIGL
| Q1 26 | — | — | ||
| Q4 25 | $70.2M | — | ||
| Q3 25 | $16.5M | — | ||
| Q2 25 | $16.7M | — | ||
| Q1 25 | $30.6M | — | ||
| Q4 24 | $55.2M | — | ||
| Q3 24 | $15.7M | — | ||
| Q2 24 | $7.0M | — |
自由现金流率IBCPRIGL
| Q1 26 | — | — | ||
| Q4 25 | 120.3% | — | ||
| Q3 25 | 28.9% | — | ||
| Q2 25 | 29.8% | — | ||
| Q1 25 | 56.5% | — | ||
| Q4 24 | 89.1% | — | ||
| Q3 24 | 30.6% | — | ||
| Q2 24 | 12.3% | — |
资本支出强度IBCPRIGL
| Q1 26 | — | — | ||
| Q4 25 | 11.1% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 12.8% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 3.1% | — |
现金转化率IBCPRIGL
| Q1 26 | — | — | ||
| Q4 25 | 4.13× | 0.08× | ||
| Q3 25 | 1.04× | 0.86× | ||
| Q2 25 | 1.12× | 0.51× | ||
| Q1 25 | 2.03× | -0.08× | ||
| Q4 24 | 3.42× | 1.01× | ||
| Q3 24 | 1.25× | 1.75× | ||
| Q2 24 | 0.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IBCP
| Net Interest Income | $46.9M | 80% |
| Noninterest Income | $12.0M | 20% |
RIGL
暂无分部数据
